BUSINESSQUARTZ
Procter & Gamble is buying supplement brand Thorne for $3.8 billion
Procter & Gamble is acquiring supplement brand Thorne for $3.8 billion, with the deal expected to close later this year. The acquisition will add Thorne to P&G's existing supplements portfolio, which includes Metamucil, Align Probiotic, and New Chapter.
Mentioned
Related Signal
Adjacent reporting
- Procter & Gamble will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC
- Unilever is exploring a bid for supplements maker Thorne in a potential $4 billion deal
- STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal
- STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more